Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1980 Oct;66(4):688–695. doi: 10.1172/JCI109906

Plasma content of B6 vitamers and its relationship to hepatic vitamin B6 metabolism.

L Lumeng, A Lui, T K Li
PMCID: PMC371643  PMID: 7419716

Abstract

The plasma content of B6 vitamers is governed by, among other factors, dietary supply and metabolic interconversion. This study examines the effect of pyridoxine supplementation on the plasma content of B6 vitamers and pyridoxic acid in man, and the metabolic conversion and release of B6 compounds in isolated rat hepatocytes. Six healthy human subjects were given 100 mg pyridoxine-HCl/d orally for 1--3 wk. Before pyridoxine supplementation, the mean total plasma level of B6 vitamers was 114 +/- 9 nM; and pyridoxal-P, pyridoxamine-P, pyridoxal, pyridoxine, and pyridoxamine accounted for 54, 3, 11, 27, and 5%, respectively. Plasma level of pyridoxic acid was 40 +/- 7 nM. Thus, pyridoxal-P is the principal B6 vitamer in plasma. During pyridoxine supplementation, mean plasma levels of the B6 vitamers and pyridoxic acid increased to 655 +/- 122 and 222 +/- 55 nM, respectively. The plasma content of pyridoxal-P and pyridoxic acid increased 6--7-fold and that of pyridoxal, 12-fold, but the pyridoxine level did not increase. Isolated hepatocytes, 1 g/15 ml, were incubated for 2 h with 3.33 microM [14C]pyridoxine (6 microCi/mumol). At zero time, the cells contained about 35 nmol pyridoxal-P and 25 nmol pyridoxamine-P. After 2 h incubation, the cellular content of pyridoxal-P and pyridoxamine-P did not change significantly, but the medium contained 5.9 nmol pyridoxal-P, 0.3 nmol pyridoxamine-P, 7.2 nmol pyridoxal, 26.6 nmol pyridoxine, 0.3 nmol pyridoxamine, and 7.5 nmol pyridoxic acid. Whereas the specific radioactivity of pyridoxal-P, pyridoxal, and pyridoxic acid in the medium approached that of [14C]pyridoxine, the specific radioactivity of cellular pyridoxal-P and pyridoxamine-P was only 20% of that of pyridoxine. Thus, newly synthesized pyridoxal-P is not freely exchangeable with endogenous pyridoxal-P, but is preferentially released or degraded to pyridoxal and pyridoxic acid. The latter B6 compounds are also released. These results suggest that orally ingested pyridoxine is rapidly metabolized in liver and its products are released into the circulation in the form of pyridoxal-P, pyridoxal, and pyridoxic acid.

Full text

PDF
688

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson B. B., Fulford-Jones C. E., Child J. A., Beard M. E., Bateman C. J. Conversion of vitamin B 6 compounds to active forms in the red blood cell. J Clin Invest. 1971 Sep;50(9):1901–1909. doi: 10.1172/JCI106682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson B. B., Newmark P. A., Rawlins M., Green R. Plasma binding of vitamin B6 compounds. Nature. 1974 Aug 9;250(5466):502–504. doi: 10.1038/250502a0. [DOI] [PubMed] [Google Scholar]
  3. Bell R. R., Haskell B. E. Metabolism of vitamin B 6 in the I-strain mouse. I. Absorption, excretion, and conversion of vitamin to enzyme co-factor. Arch Biochem Biophys. 1971 Dec;147(2):588–601. doi: 10.1016/0003-9861(71)90417-6. [DOI] [PubMed] [Google Scholar]
  4. Bosron W. F., Veitch R. L., Lumeng L., Li T. K. Subcellular localization and identification of pyridoxal 5'-phosphate-binding proteins in rat liver. J Biol Chem. 1978 Mar 10;253(5):1488–1492. [PubMed] [Google Scholar]
  5. Bukin Iu V. Aktivnost' piridoksal'kinazy i soderzhanie piridoksal'-P v tkaniakh mlekopitaiushchikh v norme i pri nekotorykh éksperimental'nykh vozdeistviiakh. Biokhimiia. 1976 Jan;41(1):81–90. [PubMed] [Google Scholar]
  6. Chabner B., Livingston D. A simple enzymic assay for pyridoxal phosphate. Anal Biochem. 1970 Apr;34(2):413–423. doi: 10.1016/0003-2697(70)90126-0. [DOI] [PubMed] [Google Scholar]
  7. Chauhan M. S., Dakshinamurti K. Fluorometric assay of pyridoxal and pyridoxal 5'-phosphate. Anal Biochem. 1979 Jul 15;96(2):426–432. doi: 10.1016/0003-2697(79)90603-1. [DOI] [PubMed] [Google Scholar]
  8. Colombini C. E., McCoy E. E. Vitamin B6 metabolism. The utilization of [14C]pyridoxine by the normal mouse. Biochemistry. 1970 Feb 3;9(3):533–538. doi: 10.1021/bi00805a012. [DOI] [PubMed] [Google Scholar]
  9. Contractor S. F., Shane B. Estimation of vitamin B6 compounds in human blood and urine. Clin Chim Acta. 1968 Jul;21(1):71–77. doi: 10.1016/0009-8981(68)90012-0. [DOI] [PubMed] [Google Scholar]
  10. Contractor S. F., Shane B. Metabolism of [14C] pyridoxol in the pregnant rat. Biochim Biophys Acta. 1971 Jan 26;230(1):127–136. doi: 10.1016/0304-4165(71)90060-2. [DOI] [PubMed] [Google Scholar]
  11. Edmondson J. W., Lumeng L., Li T. K. Comparative studies of alanine and alpha-aminoisobutyric acid uptake by freshly isolated rat liver cells. J Biol Chem. 1979 Mar 10;254(5):1653–1658. [PubMed] [Google Scholar]
  12. Edmondson J. W., Lumeng L., Li T. K. Direct measurement of active transport systems for alanine in freshly isolated rat liver cells. Biochem Biophys Res Commun. 1977 Jun 6;76(3):751–757. doi: 10.1016/0006-291x(77)91564-9. [DOI] [PubMed] [Google Scholar]
  13. Johansson S., Lindstedt S., Tiselius H. G. Metabolic interconversions of different forms of vitamin B6. J Biol Chem. 1974 Oct 10;249(19):6040–6046. [PubMed] [Google Scholar]
  14. Johansson S., Lindstedt S., Tiselius H. G. Metabolism of [3H8] pyridoxine in mice. Biochemistry. 1968 Jun;7(6):2327–2332. doi: 10.1021/bi00846a039. [DOI] [PubMed] [Google Scholar]
  15. LYON J. B., Jr, BAIN J. A., WILLIAMS H. L. The distribution of vitamin B6 in the tissues of two inbred strains of mice fed complete and vitamin B6-deficient rations. J Biol Chem. 1962 Jun;237:1989–1991. [PubMed] [Google Scholar]
  16. Lumeng L., Brashear R. E., Li T. K. Pyridoxal 5'-phosphate in plasma: source, protein-binding, and cellular transport. J Lab Clin Med. 1974 Sep;84(3):334–343. [PubMed] [Google Scholar]
  17. Lumeng L. Hormonal control of ornithine decarboxylase in isolated liver cells and the effect of ethanol oxidation. Biochim Biophys Acta. 1979 Nov 1;587(4):556–566. doi: 10.1016/0304-4165(79)90008-4. [DOI] [PubMed] [Google Scholar]
  18. Lumeng L. The role of acetaldehyde in mediating the deleterious effect of ethanol on pyridoxal 5'-phosphate metabolism. J Clin Invest. 1978 Aug;62(2):286–293. doi: 10.1172/JCI109128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Merrill A. H., Horiike K., McCormick D. B. Evidence for the regulation of pyridoxal 5-phosphate formation in liver by pyridoxamine (pyridoxine) 5 -phosphate oxidase. Biochem Biophys Res Commun. 1978 Aug 14;83(3):984–990. doi: 10.1016/0006-291x(78)91492-4. [DOI] [PubMed] [Google Scholar]
  20. Mitchell D., Wagner C., Stone W. J., Wilkinson G. R., Schenker S. Abnormal regulation of plasma pyridoxal 5'-phosphate in patients with liver disease. Gastroenterology. 1976 Dec;71(6):1043–1049. [PubMed] [Google Scholar]
  21. REDDY S. K., REYNOLDS M. S., PRICE J. M. The determination of 4-pyridoxic acid in human urine. J Biol Chem. 1958 Sep;233(3):691–696. [PubMed] [Google Scholar]
  22. Sauberlich H. E., Canham J. E., Baker E. M., Raica N., Jr, Herman Y. F. Biochemical assessment of the nutritional status of vitamin B 6 in the human. Am J Clin Nutr. 1972 Jun;25(6):629–642. doi: 10.1093/ajcn/25.6.629. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES